[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Tentative Approvals - November 2005

  ANDA Number Generic Drug Name Applicant Tentative Approval Date
1 77-695 LAMIVUDINE ORAL SOLUTION, 10 MG/ML   AUROBINDO PHARMA LIMITED 11/4/2005
2 77-237 ZALEPLON CAPSULES, 5 MG AND 10 MG   ROXANE LABORATORIES, INC. 11/4/2005
3 77-284 BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS USP, 150 MG AND 300 MG   ANCHEN PHARMACEUTICALS, INC. 11/14/2005
4 76-948 GATIFLOXACIN TABLETS, 200 MG AND 400 MG   ZYDUS PHARMACEUTICALS USA, INC. 11/25/2005 
5 77-239 ZALEPON CAPSULES, 5 MG AND 10 MG   TEVA PHARMACEUTICALS USA 11/25/2005 
6 76-310 CABERGOLINE TABLETS, 0.5 MG   PAR PHARMACEUTICAL INC. 11/30/2005 

Back to Top     Back to Approvals

Date created: December 20, 2005

horizonal rule

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research